Relationship between illness perception and quality of life in prostate cancer survivors

Tajik, Mohammad; Salehi, Shiva; Nasrollah, Sepideh

Volume 33, Issue 1 (Articles In Press 2026) J Transl Med Res. 2026, 33(1): 0-0 | Back to browse issues page

Research code: 163252647

Ethics code: IR.IAU.TMU.REC.1404.128

Mendeley

Zotero

RefWorks

Tajik M, Salehi S, Nasrollah S. Relationship between illness perception and quality of life in prostate cancer survivors. J Transl Med Res. 2026; 33 (1)
URL: http://journal.bums.ac.ir/article-1-3600-en.html

Relationship between illness perception and quality of life in prostate cancer survivors

Mohammad Tajik¹

, Shiva Salehi ^*²

, Sepideh Nasrollah¹

1- Department of Nursing, TeMS.C., Islamic Azad University, Tehran, Iran
2- Department of Nursing, TeMS.C., Islamic Azad University, Tehran, Iran , shsalehi@iautmu.ac.ir

Abstract: (255 Views)

Background and Aims: In the survival stage of Prostate cancer, quality of life is one of the key indicators of health outcomes. On the other hand, how patients perceive their illness can influence their adaptation, health-related behaviors, and ultimately their quality of life. The present aimed to determine the relationship between disease perception and quality of life among prostate cancer survivors.
Materials and Methods: This descriptive-correlational study included 230 prostate cancer survivors referred to Labafinejad Hospital through convenience sampling during 3 months. The required data were collected using the demographic characteristics form, the Broadbent illness perception questionnaire, and the EORTC QLQ-C30 quality of life questionnaire. The data were then analyzed using SPSS software (version 22).
Results: Analyses showed a positive and significant correlation (r=0.544) between illness perception and overall quality of life, such that a more realistic perception of illness was associated with a higher quality of life score. Moreover, adjusted regression analysis showed that the variables "ability to understand illness" (r=0.449, P<0.001) and "cognitive illness representation" (r=0.324, P<0.001) explained 29.9% of the quality of life in survivors.
Conclusion: A positive and significant relationship was noted between the quality of life and the perception of disease, suggesting that a realistic cognitive representation of illness may contribute to better adaptation. Therefore, future interventions should be taken into consideration to improve patients' accurate perception of their disease in order to enhance their quality of life.

Keywords: Illness perception, Prostate cancer, Quality of life, Survivors

Full-Text [PDF 594 kb] (68 Downloads)

Type of Study: Original Article | Subject: Medical-Surgical Nursing
Received: 2026/02/20 | Accepted: 2026/05/2 | ePublished: 2026/06/5

References

1. Kaler J, Hussain A, Haque A, Naveed H, Patel S. A comprehensive review of pharmaceutical and surgical interventions of prostate cancer. Cureus. 2020;12(11). DOI: 10.7759/cureus.11617 [DOI:10.7759/cureus.11617]

2. Moradi A, Zamani M, Moudi E. A systematic review and meta-analysis on incidence of prostate cancer in Iran. Health Promot Perspect. 2019;9(2):92. URL: DOI: 10.15171/hpp.2019.13 [DOI:10.15171/hpp.2019.13] [PMID] [PMCID]

3. Shetty R, Mathew RT, Vijayakumar M. Incidence and pattern of distribution of cancer in India: A secondary data analysis from six population-based cancer registries. Cancer Res Stat Treat. 2020;3(4):678-82. DOI: 10.4103/crst.crst_290_20 [DOI:10.4103/crst.crst_290_20]

4. World Health Organization. Global Cancer Observatory (GCO). Geneva: World Health Organization; 2020 [cited 2020 Apr 12]. Available from: https://gco.iarc.fr/.

5. Shafiee G, Mousavian A-h, Sheidaei A, Ebrahimi M, Khatami F, Gohari K, et al. The 15-year national trends of genital cancer incidence among Iranian men and women; 2005-2020. BMC Public Health. 2023;23(1):495. DOI: 10.1186/s12889-023-15417-0 [DOI:10.1186/s12889-023-15417-0] [PMID] [PMCID]

6. Aliakbari F, Ghanbari MA, Khayamzadeh M, Hajian MR, Allameh F, Ahadi M, et al. Five-year Survival Rate of Prostate Cancer in Iran: Results of the national cancer-registry system during 2010-2015. Archi of Men's Heal. 2020;4(1):e4-e. DOI: 10.22037/mhj.v4i1.30451

7. Esmaeilzadeh N, Salehi Moghaddam A, Khoshdel A.R. Geographic distribution of important cancers in Iran. Hormozgan Medical Journal. 2015;19(2):57-66. URL: https://hmj.hums.ac.ir/Article/87428

8. Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, et al. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021;4(6):877-92. DOI: 10.1016/j.euo.2021.09.006 [DOI:10.1016/j.euo.2021.09.006] [PMID]

9. Basiri A, Eshrati B, Zarehoroki A, Golshan S, Shakhssalim N, Khoshdel A, et al. Incidence, Gleason score and ethnicity pattern of prostate cancer in the multi-ethnicity country of Iran during 2008-2010. UrolJ. 2020; 17(6): 602-6. DOI:10.22037/uj.v0i0.5618

10. Dupont WD, Breyer JP, Johnson SH, Plummer WD, Smith JR. Prostate cancer risk variants of the HOXB genetic locus. Sci Rep. 2021;11(1):11385. DOI:10.1038/s41598-021-89399-7 [DOI:10.1038/s41598-021-89399-7] [PMID] [PMCID]

11. Fay EK, Graff JN. Immunotherapy in prostate cancer. Cancers. 2020;12(7):1752. URL: https://pubmed.ncbi.nlm.nih.gov/32630247/ [DOI:10.3390/cancers12071752] [PMID] [PMCID]

12. Gerard S, Mourey L, Briand M, Delaunay B, Balardy L. Prostate diseases. Pathy's Principles and Practice of Geriatric Medicine. 2022;2:1136-52. DOI: 10.1002/9781119484288.ch89 [DOI:10.1002/9781119484288.ch89]

13. Houédé N, Rébillard X, Bouvet S, Kabani S, Fabbro-Peray P, Trétarre B, et al. Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: an observational case-control study. BMC cancer. 2020;20:1-12. DOI:10.1186/s12885-020-07244-y [DOI:10.1186/s12885-020-07244-y] [PMID] [PMCID]

14. Sadeghpour M, Fereydooni-Moghadam M, Namnabati M. The impact of Kobasa and Maddi hardiness model on stress and hardiness of Iranian pediatric nurses: A clinical trial study. Iran J Nurs Midwifery Res. 2021;26(1):42-6. DOI:10.4103/ijnmr.IJNMR_128_20 [DOI:10.4103/ijnmr.IJNMR_128_20] [PMID] [PMCID]

15. Yazdanpanah O, Benjamin DJ, Rezazadeh Kalebasty A. Prostate cancer in sexual minorities: epidemiology, screening and diagnosis, treatment, and quality of life. Cancers. 2023;15(9):2654. DOI:10.3390/cancers15092654 [DOI:10.3390/cancers15092654] [PMID] [PMCID]

16. Rendeiro JA, Rodrigues CAMP, de Barros Rocha L, Rocha RSB, da Silva ML, da Costa Cunha K. Physical exercise and quality of life in patients with prostate cancer: systematic review and meta-analysis.Support Care Cancer. 2021; 29(9):4911-9. DOI:10.1007/s00520-021-06095-y [DOI:10.1007/s00520-021-06095-y] [PMID]

17. Volakakis N, Pylli M, Raftopoulos V, Kyrkou I, Xanthos T, Deltsidou A. Exploration of the factors that influence perceived quality of patient centered care among cancer survivors: a systematic review. Eur J Oncol Nurs. 2024;68:102503. DOI: 10.1016/j.ejon.2024.102503 [DOI:10.1016/j.ejon.2024.102503] [PMID]

18. Man MA, Toma C, Motoc NS, Necrelescu OL, Bondor CI, Chis AF, et al. Disease perception and coping with emotional distress during COVID-19 pandemic: a survey among medical staff. Int J Environ Res Public Health. 2020;17(13):4899. DOI: 10.3390/ijerph17134899 [DOI:10.3390/ijerph17134899] [PMID] [PMCID]

19. Hagger MS, Orbell S. The common sense model of illness self-regulation: a conceptual review and proposed extended model. Health psychology review. 2022;16(3):347-77. DOI: 10.1080/17437199.2021.1878050 [DOI:10.1080/17437199.2021.1878050] [PMID]

20. Borelli E, Bigi S, Potenza L, Eliardo S, Artioli F, Mucciarini C, et al. Changes in cancer patients' and caregivers' disease perceptions while receiving early palliative care: a qualitative and quantitative analysis. The Oncologist. 2021;26(12):e2274-e87. URL: https://pubmed.ncbi.nlm.nih.gov/34510624/ [DOI:10.1002/onco.13974] [PMID] [PMCID]

21. Ferreira LN, Pereira LN, da Fé Brás M, Ilchuk K. Quality of life under the COVID-19 quarantine. Qual Life Res. 2021;30:1389-405. DOI: 10.1007/s11136-020-02724-x [DOI:10.1007/s11136-020-02724-x] [PMID] [PMCID]

22. Karimi-Ghasemabad S, Akhbari B, Saeedi A, Talebian Moghaddam S, Nakhostin Ansari N. The Persian brief illness perception questionnaire: Validation in patients with chronic nonspecific low back pain. Sci World J. 2021;2021(1):3348011. DOI: 10.1155/2021/3348011 [DOI:10.1155/2021/3348011] [PMID] [PMCID]

23. Khazaeli N, Golshiri P, Farajzadegan Z, Hemati S, Amouheidari A, Hakimian MR, et al. Evaluating the validity and reliability of Persian version of the European Organization for Research and Treatment of Cancer Quality of Life questionnaire for colorectal Cancer (EORTC QLQ-CR29). J Isfahan Med Sch. 2014;32(276):228-42. URL: https://jims.mui.ac.ir/article_14283.html?lang=en

24. Safaee A, Moghim Dehkordi B. Validation study of a quality of life (QOL) questionnaire for use in Iran. Asian Pac J Cancer Prev. 2007;8(4):543-6. URL: https://pubmed.ncbi.nlm.nih.gov/18260726/

25. Momennasab M, Ghorbani F, Yektatalab S, Magharei M, Tehranineshat B. The effect of spiritual group therapy on the quality of life and empowerment of women with breast cancer: A randomized clinical trial in Iran. J Relig Health. 2024;63(1):1504-22. DOI: 10.1007/s10943-024-02009-4 [DOI:10.1007/s10943-024-02009-4] [PMID]

26. Kasnavieh MH, Veisi M, Amerzadeh M, Hosseinifard H, Tahmasebi A, Riahi M. Investigating Cancer Patients' Quality of Life During the COVID-19 Outbreak: A Study from Iran. Shiraz E-Med J. 2024;25(1): e138228. DOI: 10.5812/semj-138228 [DOI:10.5812/semj-138228]

27. Cannon M, Crede M, Kimber JM, Brunkow A, Nelson R, McAndrew LM. The common‐sense model and mental illness outcomes: A meta‐analysis. Clin Psychol Psychother. 2022;29(4):1186-202. DOI: 10.1002/cpp.2721 [DOI:10.1002/cpp.2721] [PMID]

28. Morgan SP, Lengacher CA, Rodriguez CS. Caregiver burden in caregivers of patients with advanced stage cancer: A concept analysis. Eur J Oncol Nurs. 2022;60:102152. DOI: 10.1016/j.ejon.2022.102152 [DOI:10.1016/j.ejon.2022.102152] [PMID]

29. Glattacker M, Rudolph M, Bengel J, von der Warth R. Illness beliefs, treatment beliefs, and fulfilled treatment expectations in psychosomatic rehabilitation: associations with patient satisfaction. Pati Pref Adher. 2022:3303-17. URL: https://pubmed.ncbi.nlm.nih.gov/36545541/ [DOI:10.2147/PPA.S390596] [PMID] [PMCID]

30. Doshmangir L, Hasanpoor E, Abou Jaoude GJ, Eshtiagh B, Haghparast-Bidgoli H. Incidence of catastrophic health expenditure and its determinants in cancer patients: a systematic review and meta-analysis. Appl Health Econ Health Policy. 2021;19(6):839-55. DOI: 10.1007/s40258-021-00672-2 [DOI:10.1007/s40258-021-00672-2] [PMID]

31. Giesinger JM, Efficace F, Aaronson N, Calvert M, Kyte D, Cottone F, et al. Past and current practice of patient-reported outcome measurement in randomized cancer clinical trials: a systematic review. Val in Heal. 2021;24(4):585-91. DOI: 10.1016/j.jval.2020.11.004 [DOI:10.1016/j.jval.2020.11.004] [PMID]

32. Abrams HR, Durbin S, Huang CX, Johnson SF, Nayak RK, Zahner GJ, et al. Financial toxicity in cancer care: origins, impact, and solutions. Transl Behav Med. 2021;11(11):2043-54. URL: https://pubmed.ncbi.nlm.nih.gov/34850932/ [DOI:10.1093/tbm/ibab091] [PMID]

33. Szabados M, Farkas N, Fleisz A, Takács K, Juhász O, Hernádfői M, et al. The Hungarian cross-cultural adaptation of the MMQL-AF for measuring quality of life in adolescents with cancer. Sci Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/?term=%22Fleisz%20A%22%5BAuthor%5D [DOI:10.1038/s41598-025-33243-9] [PMID] [PMCID]

34. Kvarnström K, Westerholm A, Airaksinen M, Liira H. Factors contributing to medication adherence in patients with a chronic condition: a scoping review of qualitative research. Pharmaceutics. 2021;13(7):1100. DOI: 10.3390/pharmaceutics13071100 [DOI:10.3390/pharmaceutics13071100] [PMID] [PMCID]

35. Ge H, Zhang L, Ma X, Li W, Li S. Symptom Experiences before Medical Help‐Seeking and Psychosocial Responses of Patients with Esophageal Cancer: A Qualitative Study. Eur J Cancer Care. 2023;2023(1):6506917. DOI: 10.1155/2023/6506917 [DOI:10.1155/2023/6506917]

36. MacDonald C, Ilie G, Kephart G, Rendon R, Mason R, Bailly G, et al. Mediating effects of self-efficacy and illness perceptions on mental health in men with localized prostate cancer: a secondary analysis of the prostate cancer patient empowerment program (PC-PEP) randomized controlled trial. Cancers. 2024;16(13):2352. URL: https://pubmed.ncbi.nlm.nih.gov/39001414/ [DOI:10.3390/cancers16132352] [PMID] [PMCID]

37. Lutgendorf SK, Anderson B, Rothrock N, Buller RE, Sood AK, Sorosky JI. Quality of life and mood in women receiving extensive chemotherapy for gynecologic cancer. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2000;89(6):1402-11. DOI: 10.1002/1097-0142(20000915) URL: https://pubmed.ncbi.nlm.nih.gov/11002237/ https://doi.org/10.1002/1097-0142(20000915)89:6<1402::AID-CNCR26>3.0.CO;2-H [DOI:10.1002/1097-0142(20000915)89:63.0.CO;2-H] [PMID]

38. Cheng C, Yang CY, Inder K, Chan SW-C. Illness perceptions, coping strategies, and quality of life in people with multiple chronic conditions. J Nurs Scholarsh. 2020;52(3):145-54. DOI: 10.1111/jnu.12540 [DOI:10.1111/jnu.12540] [PMID]